Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Canevelli

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 20, 2014
Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS studyMarco Canevelli, Nawal Adali, Eirini Kelaiditi, et al.
Journal of the American Geriatrics Society|July 31, 2021
"Real world" eligibility for aducanumabMarco Canevelli, Paolo Dionigi Rossi, Paolo Astrone, et al.
Expert Review of Neurotherapeutics|November 17, 2023
Advances in amyloid-targeting monoclonal antibodies for Alzheimer's disease: clinical and public health issuesSimone Salemme, Antonio Ancidoni, Nicoletta Locuratolo, et al.
Aging Clinical and Experimental Research|March 8, 2019
Counting deficits or diseases? The agreement between frailty and multimorbidity in subjects with cognitive disturbancesMarco Canevelli, Riccardo Raganato, Francesca Remiddi, et al.
Frontiers in Medicine|November 23, 2017
Spontaneous Reversion of Clinical Conditions Measuring the Risk Profile of the Individual: From Frailty to Mild Cognitive ImpairmentMarco Canevelli, Giuseppe Bruno, Francesca Remiddi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 3, 2025
Frailty and hospital outcomes among patients with neurological disordersMarco Toccaceli Blasi, Fabrizio Raffaele, Daniele Belvisi, et al.
Frontiers in Neurology|December 13, 2017
External Validity of Randomized Controlled Trials on Alzheimer's Disease: The Biases of Frailty and Biological AgingMarco Canevelli, Alessandro Trebbastoni, Federica Quarata, et al.
Mechanisms of Ageing and Development|June 7, 2019
Role of frailty in the assessment of cognitive functioningMarco Canevelli, Matteo Cesari, Riccardo Raganato, et al.
Acta Neurologica Scandinavica|October 18, 2019
A systematic review on the epidemiology of normal pressure hydrocephalusValerio Zaccaria, Ilaria Bacigalupo, Giuseppe Gervasi, et al.
Journal of Neurology|March 19, 2013
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS studyMarco Canevelli, Nawal Adali, Christelle Cantet, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 20, 2014
Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS studyMarco Canevelli, Nawal Adali, Eirini Kelaiditi, et al.
Journal of the American Geriatrics Society|July 31, 2021
"Real world" eligibility for aducanumabMarco Canevelli, Paolo Dionigi Rossi, Paolo Astrone, et al.
Expert Review of Neurotherapeutics|November 17, 2023
Advances in amyloid-targeting monoclonal antibodies for Alzheimer's disease: clinical and public health issuesSimone Salemme, Antonio Ancidoni, Nicoletta Locuratolo, et al.
Aging Clinical and Experimental Research|March 8, 2019
Counting deficits or diseases? The agreement between frailty and multimorbidity in subjects with cognitive disturbancesMarco Canevelli, Riccardo Raganato, Francesca Remiddi, et al.
Frontiers in Medicine|November 23, 2017
Spontaneous Reversion of Clinical Conditions Measuring the Risk Profile of the Individual: From Frailty to Mild Cognitive ImpairmentMarco Canevelli, Giuseppe Bruno, Francesca Remiddi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 3, 2025
Frailty and hospital outcomes among patients with neurological disordersMarco Toccaceli Blasi, Fabrizio Raffaele, Daniele Belvisi, et al.
Frontiers in Neurology|December 13, 2017
External Validity of Randomized Controlled Trials on Alzheimer's Disease: The Biases of Frailty and Biological AgingMarco Canevelli, Alessandro Trebbastoni, Federica Quarata, et al.
Mechanisms of Ageing and Development|June 7, 2019
Role of frailty in the assessment of cognitive functioningMarco Canevelli, Matteo Cesari, Riccardo Raganato, et al.
Acta Neurologica Scandinavica|October 18, 2019
A systematic review on the epidemiology of normal pressure hydrocephalusValerio Zaccaria, Ilaria Bacigalupo, Giuseppe Gervasi, et al.
Journal of Neurology|March 19, 2013
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS studyMarco Canevelli, Nawal Adali, Christelle Cantet, et al.
Pageof 16